Article ID Journal Published Year Pages File Type
2502445 International Journal of Pharmaceutics 2013 10 Pages PDF
Abstract

•The preparation of chimeric advanced Drug Delivery nano Systems (aDDnSs) composed of lipid and gradient block copolymer and their stability studies.•The morphological characteristics (df) changed in different colloidal conditions of temperature, detecting differences that the physicochemical characteristics did not reveal.•The fractal analysis offers a quantification of the morphology/structure of chimeric nanocontainers.•The morphology of chimeric nanocontainers did not change significantly after the incorporation of the indomethacin.•The drug release profiles because the gradient block copolymer acts as a modulator of indomethacin's.

Chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) could be defined as mixed nanosystems composed of different biomaterials that can be organized into new nanostructures that can offer advantages as drug carriers. In this work, we report on the self assembly behavior and on stability studies of chi-aDDnSs consisting of DPPC (dipalmitoylphosphatidylcholine) and poly(2-methyl-2-oxazoline)-grad-poly(2-phenyl-2-oxazoline) (MPOx) gradient copolymer in Phosphate Buffer Saline (PBS). Light scattering techniques were used in order to extract information on their physicochemical and structural characteristics (i.e. ζ-potential, Polydispersity Index (PD.I.), size/shape and morphology), while their stability was also studied as a function of gradient block copolymer content, as well as temperature. The colloidal stability of the chimeric nanovectors and their thermoresponsive behavior indicates that these nanosystems could be considered as sterically stabilized nanocontainers. DPPC:MPOx chimeric advanced Drug Delivery nano Systems were found to be effective nanocontainers for the incorporation of indomethacin (IND). The combination of gradient block copolymers with phospholipids for the development of novel chimeric nanovectors is reported for the first time and appears very promising, mostly due to the fact that the MPOx acts as a modulator for the release rate of the IND.

Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (143 K)Download as PowerPoint slide

Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmaceutical Science
Authors
, , , ,